Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat

[1]  R. Frausto,et al.  Site-Specific Production of IL-6 in the Central Nervous System Retargets and Enhances the Inflammatory Response in Experimental Autoimmune Encephalomyelitis1 , 2009, The Journal of Immunology.

[2]  J. Jansson,et al.  Interleukin‐6 Gene Knockout Influences Energy Balance Regulating Peptides in the Hypothalamic Paraventricular and Supraoptic Nuclei , 2009, Journal of neuroendocrinology.

[3]  Kortaro Tanaka,et al.  Ambivalent Aspects of Interleukin-6 in Cerebral Ischemia: Inflammatory versus Neurotrophic Aspects , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  M. Kasuga,et al.  Fat Stress and Liver Resistance , 2008, Science.

[5]  A. Mora,et al.  A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance , 2008, Science.

[6]  P. Halban,et al.  Interleukin-6 regulates pancreatic α-cell mass expansion , 2008, Proceedings of the National Academy of Sciences.

[7]  A. Morisset,et al.  Circulating IL‐6 Concentrations and Abdominal Adipocyte Isoproterenol‐stimulated Lipolysis in Women , 2008, Obesity.

[8]  M. Hoene,et al.  The role of interleukin‐6 in insulin resistance, body fat distribution and energy balance , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[9]  F. Hu,et al.  Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  M. Jensen,et al.  Regional fat deposition as a factor in FFA metabolism. , 2007, Annual review of nutrition.

[11]  W. Pan,et al.  Adipokines and the blood-brain barrier , 2007, Peptides.

[12]  B. Pedersen,et al.  Physiological roles of muscle-derived interleukin-6 in response to exercise , 2007, Current opinion in clinical nutrition and metabolic care.

[13]  S. O’Rahilly,et al.  The Hormonal Control of Food Intake , 2007, Cell.

[14]  P. Murray The JAK-STAT Signaling Pathway: Input and Output Integration1 , 2007, The Journal of Immunology.

[15]  S. Bauer,et al.  The neuropoietic cytokine family in development, plasticity, disease and injury , 2007, Nature Reviews Neuroscience.

[16]  R. Mooney Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. , 2007, Journal of applied physiology.

[17]  M. Febbraio,et al.  Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. , 2007, Journal of applied physiology.

[18]  D. Gruol,et al.  Physiological and pathological roles of interleukin-6 in the central nervous system , 1997, Molecular Neurobiology.

[19]  C. Léránth,et al.  Anorectic estrogen mimics leptin's effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals , 2007, Nature Medicine.

[20]  G. Bergström,et al.  Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  Masato Kasuga,et al.  Insulin resistance and pancreatic β cell failure , 2006 .

[22]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[23]  P. Neufer,et al.  Gene expression in human skeletal muscle: alternative normalization method and effect of repeated biopsies , 2005, European Journal of Applied Physiology.

[24]  B. Pedersen,et al.  Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans. , 2004, Journal of applied physiology.

[25]  P. Kern,et al.  Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. , 2004, American journal of physiology. Endocrinology and metabolism.

[26]  J. Jansson,et al.  Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[27]  E. Meyer,et al.  Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats , 2002, Neuroscience.

[28]  B. Lowell,et al.  βAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance , 2002, Science.

[29]  Seong-Eui Hong,et al.  Metallothionein Gene Expression in Human Adipose Tissue from Lean and Obese Subjects , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[30]  M. Schwaninger,et al.  Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity , 2002, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[31]  J. Jansson,et al.  Intracerebroventricular interleukin-6 treatment decreases body fat in rats. , 2002, Biochemical and biophysical research communications.

[32]  N. Lago,et al.  Metallothionein-1+2 Deficiency Increases Brain Pathology in Transgenic Mice with Astrocyte-Targeted Expression of Interleukin 6 , 2002, Neurobiology of Disease.

[33]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[34]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 2001, Nature Reviews Neuroscience.

[35]  C. Ohlsson,et al.  Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice. , 2001, Endocrinology.

[36]  J. Hidalgo,et al.  Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures , 2001, Neuroscience.

[37]  P. Neufer,et al.  Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. , 2000, American journal of physiology. Endocrinology and metabolism.

[38]  J. Gauldie,et al.  Endogenous interleukin‐6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice , 1999, The European journal of neuroscience.

[39]  M. Laville,et al.  Uncoupling protein-2 (UCP2) and uncoupling protein-3 (UCP3) expression in adipose tissue and skeletal muscle in humans , 1999, International Journal of Obesity.

[40]  A. Armario,et al.  IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6 , 1998, Journal of Neuroimmunology.

[41]  F E Bloom,et al.  Modulation of Hypothalamic–Pituitary–Adrenal Function by Transgenic Expression of Interleukin-6 in the CNS of Mice , 1997, The Journal of Neuroscience.

[42]  U. Otten,et al.  Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.

[43]  C. Heyser,et al.  Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Ciliberto,et al.  Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.

[45]  V. Poli,et al.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.

[46]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  N. Rothwell,et al.  Interleukin-6 is a centrally acting endogenous pyrogen in the rat. , 1991, Canadian journal of physiology and pharmacology.

[48]  A. Niijima,et al.  Neural mechanisms in the control of blood glucose concentration. , 1989, The Journal of nutrition.